Experimental immunotherapy treatment first successfully used in the 1990s is finally available for commercial use.

Over-activation of telomerase in most malignant tumors has made the unusual enzyme a prime target for drug development efforts.

New technology could fundamentally change the way cancers are tracked and treated.

UCLA-VA pilot project is nation’s first to offer veterans access to cutting-edge cancer clinical trials and state-of-the-art treatment facilities.

UC San Francisco's Dr. Laura Esserman, who leads the Athena Breast Health Network — a collaboration of the five UC medical centers — offers insights into breast cancer.

Berkeley Lab gets $1.3M to study health impacts of the stubborn, noxious residue left behind from smoked tobacco.

Zev Gartner's innovative work in 3-D tissue generation has earned him a spot on Popular Science's 'Brilliant 10' list of 2015.

Odds of breast cancer are greater when the easily transmitted bovine leukemia virus is present.

National Cancer Institute grant of $5 million will fund a massive effort to integrate data from all experimental models across all types of cancer — moving the needle forward on precision medicine.

Method combines chemotherapy drug with adoptive cell transfer, in which a patient’s own immune cells are reprogrammed to target the disease.

Pups will put their superior sense of smell to work detecting cancer, especially at early stages, in humans.

State initiative provides $1.2 million for the Genomics Institute's California Kids Cancer Comparison project.